Fulcrum Therapeutics has announced successful completion of patient enrollment in REACH Phase 3 trial
The FSHD Society is thrilled to announce a significant milestone in the battle against FSHD.
Day: 2 November 2023
The FSHD Society is thrilled to announce a significant milestone in the battle against FSHD.